An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans

  • Robert A. Scott
    MRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.
  • Laura J. Scott
    Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI
  • Reedik Mägi
    Estonian Genome Center, University of Tartu, Tartu, Estonia
  • Letizia Marullo
    Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy
  • Kyle J. Gaulton
    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.
  • Marika Kaakinen
    Department of Genomics of Common Disease, Imperial College London, London, U.K.
  • Natalia Pervjakova
    Estonian Genome Center, University of Tartu, Tartu, Estonia
  • Tune H. Pers
    Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA
  • Andrew D. Johnson
    Framingham Heart Study, Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Framingham, MA
  • John D. Eicher
    Framingham Heart Study, Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Framingham, MA
  • Anne U. Jackson
    Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI
  • Teresa Ferreira
    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.
  • Yeji Lee
    Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI
  • Clement Ma
    Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI
  • Valgerdur Steinthorsdottir
    deCODE genetics, Amgen, Inc., Reykjavik, Iceland
  • Gudmar Thorleifsson
    deCODE genetics, Amgen, Inc., Reykjavik, Iceland
  • Lu Qi
    Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA
  • Natalie R. Van Zuydam
    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.
  • Anubha Mahajan
    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.
  • Han Chen
    Human Genetics Center and Department of Epidemiology, Human Genetics & Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX
  • Peter Almgren
    Lund University Diabetes Centre and Department of Clinical Sciences Malmö, University Hospital Scania, Lund University, Malmö, Sweden
  • Ben F. Voight
    Department of Pharmacology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
  • Harald Grallert
    Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
  • Martina Müller-Nurasyid
    Institute of Genetic Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
  • Janina S. Ried
    Institute of Genetic Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
  • Nigel W. Rayner
    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.
  • Neil Robertson
    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.
  • Lennart C. Karssen
    Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
  • Elisabeth M. van Leeuwen
    Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
  • Sara M. Willems
    MRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.
  • Christian Fuchsberger
    Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI
  • Phoenix Kwan
    Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI
  • Tanya M. Teslovich
    Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI
  • Pritam Chanda
    High Throughput Biology Center, Johns Hopkins University School of Medicine, Baltimore, MD
  • Man Li
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
  • Yingchang Lu
    The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
  • Christian Dina
    l'institut du thorax, INSERM, CNRS, Centre Hospitalier Universitaire de Nantes, Université de Nantes, Nantes, France
  • Dorothee Thuillier
    Lille Institute of Biology, European Genomics Institute of Diabetes, Lille, France
  • Loic Yengo
    Lille Institute of Biology, European Genomics Institute of Diabetes, Lille, France
  • Longda Jiang
    Department of Genomics of Common Disease, Imperial College London, London, U.K.
  • Thomas Sparso
    Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  • Hans A. Kestler
    Leibniz Institute on Aging, Fritz Lipmann Institute, Jena, Germany
  • Himanshu Chheda
    Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
  • Lewin Eisele
    Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, Essen, Germany
  • Stefan Gustafsson
    Molecular Epidemiology, Department of Medical Sciences, and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
  • Mattias Frånberg
    Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
  • Rona J. Strawbridge
    Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
  • Rafn Benediktsson
    Faculty of Medicine, University of Iceland, Reykjavik, Iceland
  • Astradur B. Hreidarsson
    Landspítali University Hospital, Reykjavik, Iceland
  • Augustine Kong
    deCODE genetics, Amgen, Inc., Reykjavik, Iceland
  • Gunnar Sigurðsson
    Landspítali University Hospital, Reykjavik, Iceland
  • Nicola D. Kerrison
    MRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.
  • Jian'an Luan
    MRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.
  • Liming Liang
    Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA
  • Thomas Meitinger
    Munich Heart Alliance, German Centre for Cardiovascular Disease, Munich, Germany
  • Michael Roden
    German Center for Diabetes Research, Neuherberg, Germany
  • Barbara Thorand
    Institute of Epidemiology II, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
  • Tõnu Esko
    Estonian Genome Center, University of Tartu, Tartu, Estonia
  • Evelin Mihailov
    Estonian Genome Center, University of Tartu, Tartu, Estonia
  • Caroline Fox
    Framingham Heart Study, National Heart, Lung, and Blood Institute, Framingham, MA
  • Ching-Ti Liu
    Department of Biostatistics, Boston University School of Public Health, Boston, MA
  • Denis Rybin
    Data Coordinating Center, Boston University School of Public Health, Boston, MA
  • Bo Isomaa
    Folkhälsan Research Center, Helsinki, Finland
  • Valeriya Lyssenko
    Lund University Diabetes Centre and Department of Clinical Sciences Malmö, University Hospital Scania, Lund University, Malmö, Sweden
  • Tiinamaija Tuomi
    Folkhälsan Research Center, Helsinki, Finland
  • David J. Couper
    Collaborative Studies Coordinating Center, Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC
  • James S. Pankow
    Division of Epidemiology & Community Health, University of Minnesota, Minneapolis, MN
  • Niels Grarup
    Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  • Christian T. Have
    Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  • Marit E. Jørgensen
    Steno Diabetes Center, Gentofte, Denmark
  • Torben Jørgensen
    Research Centre for Prevention and Health, Capital Region of Denmark, Copenhagen, Denmark
  • Allan Linneberg
    Research Centre for Prevention and Health, Capital Region of Denmark, Copenhagen, Denmark
  • Marilyn C. Cornelis
    Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
  • Rob M. van Dam
    Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA
  • David J. Hunter
    Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA
  • Peter Kraft
    Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA
  • Qi Sun
    Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA
  • Sarah Edkins
    Wellcome Trust Sanger Institute, Hinxton, U.K.
  • Katharine R. Owen
    Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, U.K.
  • John R.B. Perry
    MRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.
  • Andrew R. Wood
    Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter, U.K.
  • Eleftheria Zeggini
    Wellcome Trust Sanger Institute, Hinxton, U.K.
  • Juan Tajes-Fernandes
    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.
  • Goncalo R. Abecasis
    Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI
  • Lori L. Bonnycastle
    National Human Genome Research Institute, National Institutes of Health, Bethesda, MD
  • Peter S. Chines
    National Human Genome Research Institute, National Institutes of Health, Bethesda, MD
  • Heather M. Stringham
    Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI
  • Heikki A. Koistinen
    Department of Health, National Institute for Health and Welfare, Helsinki, Finland
  • Leena Kinnunen
    Department of Health, National Institute for Health and Welfare, Helsinki, Finland
  • Bengt Sennblad
    Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
  • Thomas W. Mühleisen
    Institute of Human Genetics, University of Bonn, Bonn, Germany
  • Markus M. Nöthen
    Institute of Human Genetics, University of Bonn, Bonn, Germany
  • Sonali Pechlivanis
    Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, Essen, Germany
  • Damiano Baldassarre
    Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy
  • Karl Gertow
    Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
  • Steve E. Humphries
    Cardiovascular Genetics, BHF Laboratories, Institute Cardiovascular Sciences, University College London, London, U.K.
  • Elena Tremoli
    Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy
  • Norman Klopp
    Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
  • Julia Meyer
    Institute of Genetic Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
  • Gerald Steinbach
    Department of Clinical Chemistry and Central Laboratory, University of Ulm, Ulm, Germany
  • Roman Wennauer
    Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands
  • Johan G. Eriksson
    Folkhälsan Research Center, Helsinki, Finland
  • Satu Mӓnnistö
    Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland
  • Leena Peltonen
    Wellcome Trust Sanger Institute, Hinxton, U.K.
  • Emmi Tikkanen
    Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
  • Guillaume Charpentier
    Endocrinology-Diabetology Unit, Corbeil-Essonnes Hospital, Corbeil-Essonnes, France
  • Elodie Eury
    CNRS UMR 8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, University of Lille, Lille, France
  • Stéphane Lobbens
    CNRS UMR 8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, University of Lille, Lille, France
  • Bruna Gigante
    Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
  • Karin Leander
    Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
  • Olga McLeod
    Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
  • Erwin P. Bottinger
    The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
  • Omri Gottesman
    The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
  • Douglas Ruderfer
    Division of Psychiatric Genomics, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY
  • Matthias Blüher
    IFB AdiposityDiseases, University of Leipzig, Leipzig, Germany
  • Peter Kovacs
    IFB AdiposityDiseases, University of Leipzig, Leipzig, Germany
  • Anke Tonjes
    IFB AdiposityDiseases, University of Leipzig, Leipzig, Germany
  • Nisa M. Maruthur
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
  • Chiara Scapoli
    Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy
  • Raimund Erbel
    Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, Essen, Germany
  • Karl-Heinz Jöckel
    Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, Essen, Germany
  • Susanne Moebus
    Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, Essen, Germany
  • Ulf de Faire
    Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
  • Anders Hamsten
    Cardiovascular Medicine Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
  • Michael Stumvoll
    IFB AdiposityDiseases, University of Leipzig, Leipzig, Germany
  • Panagiotis Deloukas
    Wellcome Trust Sanger Institute, Hinxton, U.K.
  • Peter J. Donnelly
    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.
  • Timothy M. Frayling
    Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter, U.K.
  • Andrew T. Hattersley
    Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K.
  • Samuli Ripatti
    Wellcome Trust Sanger Institute, Hinxton, U.K.
  • Veikko Salomaa
    Department of Health, National Institute for Health and Welfare, Helsinki, Finland
  • Nancy L. Pedersen
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
  • Bernhard O. Boehm
    Division of Endocrinology and Diabetes, Department of Internal Medicine, University Medical Centre Ulm, Ulm, Germany
  • Richard N. Bergman
    Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA
  • Francis S. Collins
    National Human Genome Research Institute, National Institutes of Health, Bethesda, MD
  • Karen L. Mohlke
    Department of Genetics, University of North Carolina, Chapel Hill, NC
  • Jaakko Tuomilehto
    Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland
  • Torben Hansen
    Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  • Oluf Pedersen
    Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  • Inês Barroso
    Wellcome Trust Sanger Institute, Hinxton, U.K.
  • Lars Lannfelt
    Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden
  • Erik Ingelsson
    Molecular Epidemiology, Department of Medical Sciences, and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
  • Lars Lind
    Cardiovascular Epidemiology, Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
  • Cecilia M. Lindgren
    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.
  • Stephane Cauchi
    Lille Institute of Biology, European Genomics Institute of Diabetes, Lille, France
  • Philippe Froguel
    Department of Genomics of Common Disease, Imperial College London, London, U.K.
  • Ruth J.F. Loos
    The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
  • Beverley Balkau
    INSERM, CESP, UMR 1018, Villejuif, France
  • Heiner Boeing
    German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
  • Paul W. Franks
    Lund University, Malmö, Sweden
  • Aurelio Barricarte Gurrea
    Navarra Public Health Institute, Pamplona, Spain
  • Domenico Palli
    Cancer Research and Prevention Institute, Florence, Italy
  • Yvonne T. van der Schouw
    University Medical Center Utrecht, Utrecht, the Netherlands
  • David Altshuler
    Broad Institute of MIT and Harvard, Cambridge, MA
  • Leif C. Groop
    Lund University Diabetes Centre and Department of Clinical Sciences Malmö, University Hospital Scania, Lund University, Malmö, Sweden
  • Claudia Langenberg
    MRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.
  • Nicholas J. Wareham
    MRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.
  • Eric Sijbrands
    Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands
  • Cornelia M. van Duijn
    Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
  • Jose C. Florez
    Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA
  • James B. Meigs
    Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA
  • Eric Boerwinkle
    Human Genetics Center, The University of Texas Health Science Center at Houston, Houston, TX
  • Christian Gieger
    Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
  • Konstantin Strauch
    Institute of Genetic Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
  • Andres Metspalu
    Estonian Genome Center, University of Tartu, Tartu, Estonia
  • Andrew D. Morris
    Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, U.K.
  • Colin N.A. Palmer
    Pat Macpherson Centre for Pharmacogenetics and Pharmacogenomics and Biomedical Research Institute, Ninewells Hospital, University of Dundee, Dundee, U.K.
  • Frank B. Hu
    Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA
  • Unnur Thorsteinsdottir
    deCODE genetics, Amgen, Inc., Reykjavik, Iceland
  • Kari Stefansson
    deCODE genetics, Amgen, Inc., Reykjavik, Iceland
  • Josée Dupuis
    Framingham Heart Study, National Heart, Lung, and Blood Institute, Framingham, MA
  • Andrew P. Morris
    Estonian Genome Center, University of Tartu, Tartu, Estonia
  • Michael Boehnke
    Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI
  • Mark I. McCarthy
    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.
  • Inga Prokopenko
    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.

抄録

<jats:p>To characterize type 2 diabetes (T2D)-associated variation across the allele frequency spectrum, we conducted a meta-analysis of genome-wide association data from 26,676 T2D case and 132,532 control subjects of European ancestry after imputation using the 1000 Genomes multiethnic reference panel. Promising association signals were followed up in additional data sets (of 14,545 or 7,397 T2D case and 38,994 or 71,604 control subjects). We identified 13 novel T2D-associated loci (P &lt; 5 × 10−8), including variants near the GLP2R, GIP, and HLA-DQA1 genes. Our analysis brought the total number of independent T2D associations to 128 distinct signals at 113 loci. Despite substantially increased sample size and more complete coverage of low-frequency variation, all novel associations were driven by common single nucleotide variants. Credible sets of potentially causal variants were generally larger than those based on imputation with earlier reference panels, consistent with resolution of causal signals to common risk haplotypes. Stratification of T2D-associated loci based on T2D-related quantitative trait associations revealed tissue-specific enrichment of regulatory annotations in pancreatic islet enhancers for loci influencing insulin secretion and in adipocytes, monocytes, and hepatocytes for insulin action–associated loci. These findings highlight the predominant role played by common variants of modest effect and the diversity of biological mechanisms influencing T2D pathophysiology.</jats:p>

収録刊行物

  • Diabetes

    Diabetes 66 (11), 2888-2902, 2017-05-31

    American Diabetes Association

被引用文献 (9)*注記

もっと見る

問題の指摘

ページトップへ